Introduced by Eli Lilly in August 2024 in response to high demand and access barriers, Zepbound single-dose vials make it possible to receive the same active ingredient that produced up to 21% mean body weight loss in clinical trials at prices starting at $299 per month compared to a list price of over $1,086 for the autoinjector pen version
Because tirzepatide does not raise insulin levels when blood sugar is low, it has a lower risk of causing low blood sugar (hypoglycemia) compared to some older diabetes drugs like sulfonylureas or insulin
Above we have provided a Semaglutide Weight Loss Dosage Chart, but that is for Wegovy specifically, and a doctors recommendation is critically important before starting, continuing, increase in dosage, or cessation of the medication
Both medications work by mimicking natural hormones that control hunger and metabolism, but there is a slight difference in their engines. The Bottom Line: Retatrutide offers a modest increase in potential weight loss (approximately 3%), but it is still in clinical trials
